Liquid Biopsy Market is expected to reach USD 9.34 billion by 2032
Introduction The liquid biopsy market has become one of the most transformative innovations in the healthcare and diagnostics industry, providing a non-invasive, highly accurate alternative to traditional tissue biopsies. By analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and other biomarkers from blood and other body fluids, liquid biopsies offer a...
0 Комментарии 0 Поделились 4 Просмотры 0 предпросмотр